KH Neochem Co., Ltd. (TSE: 4189, President and CEO: Michio Takahashi, “KH Neochem”) will be exhibiting at the “BIO KOREA 2025 International Convention※１” held in Seoul, Korea, from May 7-9, 2025 (booth No. M７).
“BIO KOREA*” is an international conference for the biotechnologies, bio pharmaceuticals, and healthcare sectors, held annually in Korea since 2006. The event brings together pharmaceutical and biotech companies, as well as research institutions from around the world, with the aim of revitalizing the bio-health industry and promoting its global development. In addition to showcasing the latest technologies, business trends and products, BIO KOREA also facilitates business matching and networking opportunities with experts and companies.
KH Neochem aims to contribute to the advancement of biopharmaceuticals through its proprietary glycan technologies. At BIO KOREA, we will exhibit at our own booth, where we will showcase our original glycan product, GlyMuch™, including research-use glycan reagents and glycan remodeling services for proteins.
- For more details about the event, please visit the official website.
- About Glycans
KH Neochem, aiming to achieve our “VISION 2030**,” has designated “Environment,” “Healthcare,” and “Electronics” as strategic domains. “KH i-Lab,” a newly established research hub, has been dedicated to accelerating research and development and driving creation of new businesses by leveraging an open innovation strategy. In the healthcare domain, KH Neochem has focused on the potential of glycans, and has developed proprietary glycans and manufacturing technologies.
In living organisms, glycans are linked to proteins and lipids on cell surfaces and within cells. Due to modulating the function and stability of the binding substances, glycoproteins and glycolipids influence various biological events such as cell adhesion and differentiation. It has been known that many diseases and disorders are associated with glycan abnormalities. Along with nucleic acids and proteins, these glycans comprise “the third life chain” because of their involvement in various vital phenomena.
As the third life chain, glycans have been actively investigated in life science fields to elucidate vital biological processes and develop new drugs, but artificial synthesis of glycans is difficult because of the great diversity of glycan structures. Ensuring a stable and sufficient supply of glycans remains a major challenge, not only for academic research but also for industrial applications. KH Neochem has developed original glycan manufacturing technology to ensure a stable supply and is accelerating marketing efforts to explore partners for value creation through glycan applications.
■EVENT INFORMATION
| Event name | BIO KOREA 2025 International Convention |
| Organizer | BIO KOREA Organizing Committee |
| Dater | May 7(WED)-9(FRI) 2025 |
| Venue | Conference Room (3, 4F) COEX Convention & Exhibition Center 513 Yeongdong-daero, Gangnam District, Seoul, South Korea |
| Booth No. | M７ |
| Registration | Please check the official website for registration. https://www.biokorea.org/index.asp |
| Exhibit | 1.N-Glycan Reagents “ GlyMuch™” for Research-use 2.Improving the pharmacokinetics of peptides 3.Synthesis of homogeneous antibodies and antibody-drug conjugates (ADCs) via glycosylation” |
■About glycans
https://www.khneochem.co.jp/en/solution/features/glycans/
■GlyMuch™ glycans by KH Neochem
https://www.khneochem.co.jp/en/solution/features/glycans/service/
* 「BIO KOREA 2025 International Convention」
https://www.biokorea.org/index.asp
** 「VISION 2030」
https://ssl4.eir-parts.net/doc/4189/ir_material4/152214/00.pdf
250422_KH Neochem to Exhibit at BIO KOREA 2025
For inquiries regarding this matter, please contact:
・Corporate Communications and Investor Relations KH Neochem Co., Ltd.
kouhou@khneochem.co.jp
・KH i-Lab:KH Neochem innovation Laboratory
innovation@khneochem.co.jp